Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
BAA TOXWP 118/CTP-2022-112800 -EVALUATE AND PROMOTE THE USE OF CELL- AND TISSUE-BASED ASSAYS THAT MORE ACCURATELY REPRESENT HUMAN SUSCEPTIBILITY THAN ANIMAL MODELS TO ADVERSE REACTIONS AND PREDICT THRESHOLD OF TOXICOLOGICAL CONCERNS RESULTING FROM EX is a federal NONE award for Fda Office Of Acq Grant Svcs held by Georgia Tech Research Corp. Estimated value $2M ($2M obligated). Current period of performance ends Sep 29, 2025 (potential Sep 29, 2026). Last award drew 165 bidders. Place of performance: SILVER SPRING MD. Related solicitation FDABAA-22-00123.
BAA TOXWP 118/CTP-2022-112800 -EVALUATE AND PROMOTE THE USE OF CELL- AND TISSUE-BASED ASSAYS THAT MORE ACCURATELY REPRESENT HUMAN SUSCEPTIBILITY THAN ANIMAL MODELS TO ADVERSE REACTIONS AND PREDICT THRESHOLD OF TOXICOLOGICAL CONCERNS RESULTING FROM EX
Recompete timing
PublicCurrent PoP ended Sep 29, 2025 (326 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordGeorgia Tech Research Corp — $36.2M obligated across 44 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40122C00146?
75F40122C00146 (BAA TOXWP 118 ctp-2022-112800 -evaluate and) is a Fda Office Of Acq Grant Svcs award with a potential value of $2M, currently held by Georgia Tech Research Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40122C00146?
Fda Office Of Acq Grant Svcs awarded 75F40122C00146 to Georgia Tech Research Corp (potential $2M).
Who is the incumbent on 75F40122C00146?
Georgia Tech Research Corp is the incumbent with $36.2M across 44 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2025.
When does Georgia Tech Research Corp’s 75F40122C00146 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.